Difficulty: Medium
Average Score: 78%
Practice
A nurse is caring for a client prescribed the HMG CoA reductase inhibitor, atorvastatin. Which of the following should be monitored while this medication is prescribed?
Correct answer
A
Rationale
Corrected Rationale: Atorvastatin, an HMG CoA reductase inhibitor, can lead to hepatotoxicity. Therefore, monitoring liver function through regular tests is essential. Baseline liver function should be assessed, followed by tests at 12 weeks after starting therapy and periodically thereafter. This monitoring helps detect early signs of liver damage, including jaundice, nausea, and dark urine.
Incorrect Choices Rationale:
B) Renal function test is not directly affected by atorvastatin.
C) Hearing screenings and D) Visual acuity screenings are not indicated for monitoring while on atorvastatin therapy.
Incorrect Choices Rationale:
B) Renal function test is not directly affected by atorvastatin.
C) Hearing screenings and D) Visual acuity screenings are not indicated for monitoring while on atorvastatin therapy.